BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27320335)

  • 41. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
    Kersten S; Dawson MI; Lewis BA; Noy N
    Biochemistry; 1996 Mar; 35(12):3816-24. PubMed ID: 8620004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
    Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
    J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinoid X receptors: common heterodimerization partners with distinct functions.
    Lefebvre P; Benomar Y; Staels B
    Trends Endocrinol Metab; 2010 Nov; 21(11):676-83. PubMed ID: 20674387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complex effects of rexinoids on ligand dependent activation or inhibition of the xenobiotic receptor, CAR.
    Tzameli I; Chua SS; Cheskis B; Moore DD
    Nucl Recept; 2003 Jun; 1(1):2. PubMed ID: 12904257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential therapeutic uses of rexinoids.
    Leal AS; Reich LA; Moerland JA; Zhang D; Liby KT
    Adv Pharmacol; 2021; 91():141-183. PubMed ID: 34099107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinoid X receptors: X-ploring their (patho)physiological functions.
    Szanto A; Narkar V; Shen Q; Uray IP; Davies PJ; Nagy L
    Cell Death Differ; 2004 Dec; 11 Suppl 2():S126-43. PubMed ID: 15608692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo activation of PPAR target genes by RXR homodimers.
    IJpenberg A; Tan NS; Gelman L; Kersten S; Seydoux J; Xu J; Metzger D; Canaple L; Chambon P; Wahli W; Desvergne B
    EMBO J; 2004 May; 23(10):2083-91. PubMed ID: 15103326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Next-generation retinoid X receptor agonists increase ATRA signaling in organotypic epithelium cultures and have distinct effects on receptor dynamics.
    Melo N; Belyaeva OV; Berger WK; Halasz L; Yu J; Pilli N; Yang Z; Klyuyeva AV; Elmets CA; Atigadda V; Muccio DD; Kane MA; Nagy L; Kedishvili NY; Renfrow MB
    J Biol Chem; 2023 Jan; 299(1):102746. PubMed ID: 36436565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
    Altucci L; Rossin A; Hirsch O; Nebbioso A; Vitoux D; Wilhelm E; Guidez F; De Simone M; Schiavone EM; Grimwade D; Zelent A; de Thé H; Gronemeyer H
    Cancer Res; 2005 Oct; 65(19):8754-65. PubMed ID: 16204045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-talk between thyroid hormone and specific retinoid X receptor subtypes in yeast selectively regulates cognate ligand actions.
    Walfish PG; Yang YF; Ypganathan T; Chang LA; Butt TR
    Gene Expr; 1996; 6(3):169-84. PubMed ID: 9041123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR.
    Zheng W; Lu Y; Tian S; Ma F; Wei Y; Xu S; Li Y
    J Biol Chem; 2018 Aug; 293(32):12535-12541. PubMed ID: 29934308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.
    Pollinger J; Schierle S; Gellrich L; Ohrndorf J; Kaiser A; Heitel P; Chaikuad A; Knapp S; Merk D
    ACS Med Chem Lett; 2019 Sep; 10(9):1346-1352. PubMed ID: 31531208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor.
    Su Y; Zeng Z; Chen Z; Xu D; Zhang W; Zhang XK
    Curr Top Med Chem; 2017; 17(6):663-675. PubMed ID: 27320331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ligand- and DNA-induced dissociation of RXR tetramers.
    Chen ZP; Iyer J; Bourguet W; Held P; Mioskowski C; Lebeau L; Noy N; Chambon P; Gronemeyer H
    J Mol Biol; 1998 Jan; 275(1):55-65. PubMed ID: 9451439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review of the molecular design and biological activities of RXR agonists.
    de Almeida NR; Conda-Sheridan M
    Med Res Rev; 2019 Jul; 39(4):1372-1397. PubMed ID: 30941786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
    Li XY; Xiao JH; Feng X; Qin L; Voorhees JJ
    J Invest Dermatol; 1997 Apr; 108(4):506-12. PubMed ID: 9077482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases.
    van Neerven S; Kampmann E; Mey J
    Prog Neurobiol; 2008 Aug; 85(4):433-51. PubMed ID: 18554773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.